Search
Sign Up
Home
Team
Pipeline
Back
Sr89/Metastron
QBM-001
Uttroside-B
MAN-01
Investors
Back
Presentations
Stock Info
Filings
Media
News
Back
News 2024
News 2023
News 2022
News 2021
News 2020
News 2019
News 2018
News 2017
News 2016
Contact
Video & Social Media
Watch us in interviews. Follow us.
2019 News
List of articles in category 2019 News
Title
Created Date
Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
Nov 26, 2019
Q BioMed Announces FDA Approval
Nov 20, 2019
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline
Nov 05, 2019
Q BioMed Announces Commercial Partnership with Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States
Oct 03, 2019
Q BioMed Announces Legal Settlement and Acquisition of FDA approved Non-Opioid Metastatic Cancer Pain Drug
Oct 02, 2019
Q BioMed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic
Sep 11, 2019
Q Biomed And Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough In Liver Cancer
Aug 20, 2019
Q BioMed Announces Updates on Commercialization of Non-Opioid Metastatic Cancer Pain Drug
Jul 11, 2019
Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
Jun 28, 2019
Q BioMed Responds to OTC Markets Request for Clarity on Promotional Activity
Jun 24, 2019
Q BioMed Advances QBM-001 for the Treatment of Autism Spectrum Disorder Subtype
Jun 04, 2019
Biotechnology Accelerator, Q BioMed Inc., Selects 5W Public Relations as Agency of Record
May 30, 2019
Q BioMed Research Partner Mannin Research to Attend ARVO 2019 Annual Meeting
Apr 24, 2019
In a Major Breakthrough, Q BioMed Discovers First Biomarkers for Pediatric Nonverbal Autism Subgroup
Apr 10, 2019
Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster University
Mar 19, 2019
Q BioMed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression from Washington University
Mar 11, 2019
Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper
Feb 26, 2019
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research
Feb 23, 2019
Q BioMed Responds to OTC Markets Request for Clarity on Investor Awareness Activity
Feb 07, 2019
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City
Feb 05, 2019
Q BioMed to Present at 2019 BIO CEO & Investor Conference
Feb 01, 2019
Q Biomed Technology Partner Mannin Research Enters Into Collaboration With Mcmaster University For Glaucoma Drug Candidate MAN-01
Jan 25, 2019
Q BioMed Adds Clinical Psychologist at Yale’s Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001
Jan 16, 2019
Update and Outlook in a New Audio Interview
Jan 15, 2019
Q BioMed Inc Provides Shareholder Update
Jan 08, 2019